RadNet Inc. (NASDAQ:RDNT) has been given an average recommendation of “Hold” by the five ratings firms that are currently covering the firm. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $8.00.
Several research analysts have issued reports on RDNT shares. Jefferies Group LLC set a $7.00 price target on shares of RadNet and gave the stock a “hold” rating in a report on Thursday, March 16th. Zacks Investment Research lowered shares of RadNet from a “buy” rating to a “hold” rating in a report on Wednesday, January 11th.
TRADEMARK VIOLATION NOTICE: “Analysts Set RadNet Inc. (RDNT) PT at $8.33” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://www.com-unik.info/2017/04/21/radnet-inc-rdnt-given-average-rating-of-hold-by-brokerages-updated-updated.html.
Several hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP raised its stake in RadNet by 8.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,375,696 shares of the medical research company’s stock valued at $8,873,000 after buying an additional 103,885 shares in the last quarter. Robotti Robert raised its stake in RadNet by 45.3% in the third quarter. Robotti Robert now owns 674,966 shares of the medical research company’s stock valued at $4,995,000 after buying an additional 210,491 shares in the last quarter. Redwood Investments LLC raised its stake in RadNet by 42.2% in the third quarter. Redwood Investments LLC now owns 629,048 shares of the medical research company’s stock valued at $4,655,000 after buying an additional 186,618 shares in the last quarter. State Street Corp raised its stake in RadNet by 9.1% in the fourth quarter. State Street Corp now owns 614,416 shares of the medical research company’s stock valued at $3,962,000 after buying an additional 51,027 shares in the last quarter. Finally, Renaissance Technologies LLC raised its stake in RadNet by 31.2% in the fourth quarter. Renaissance Technologies LLC now owns 570,101 shares of the medical research company’s stock valued at $3,677,000 after buying an additional 135,701 shares in the last quarter. Institutional investors own 46.76% of the company’s stock.
Shares of RadNet (NASDAQ:RDNT) traded down 1.63% during midday trading on Monday, hitting $6.05. 120,798 shares of the company’s stock traded hands. The company has a 50 day moving average price of $5.75 and a 200 day moving average price of $6.30. RadNet has a 1-year low of $4.83 and a 1-year high of $7.98. The firm has a market capitalization of $285.55 million, a price-to-earnings ratio of 40.33 and a beta of 1.40.
RadNet (NASDAQ:RDNT) last released its quarterly earnings results on Tuesday, March 14th. The medical research company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.03. RadNet had a return on equity of 22.29% and a net margin of 0.51%. The firm had revenue of $224.90 million for the quarter, compared to the consensus estimate of $226.27 million. During the same quarter in the previous year, the business posted $0.02 EPS. The firm’s revenue for the quarter was up 4.2% compared to the same quarter last year. Equities analysts anticipate that RadNet will post $0.27 earnings per share for the current year.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
What are top analysts saying about RadNet Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RadNet Inc. and related companies.